Chinese startup iMeddy provides free video medical consultation to COVID-19 patients

Amid the severity of the fifth wave of the COVID-19 pandemic, a startup nurtured by The Hong Kong Polytechnic University...

March 25, 2022 | Friday | News
Singapore recommends second booster dose of mRNA vaccine for 80+

The Expert Committee on COVID-19 Vaccination (EC19V) in Singapore has been closely reviewing the data regarding the need...

March 25, 2022 | Friday | News
Australia to manufacture mRNA vaccines against future pandemics

An in-principle agreement was first announced in December last year for a factory to produce 25 million doses a year fro...

March 24, 2022 | Thursday | News
Novavax and SII gets EUA for COVID-19 vaccines for adolescents in India

Novavax, a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infect...

March 23, 2022 | Wednesday | News
Malaysia approves CanSinoBIO's COVID-19 vaccine as heterologous booster

China-based CanSino Biologics has announced that its Recombinant Novel Coronavirus Vaccine (Convidecia) has been approve...

March 23, 2022 | Wednesday | News
Detecting COVID-19 using only a smartphone

ResApp Health announced positive results for a new novel cough audio-based COVID-19 screening test that only requires a ...

March 22, 2022 | Tuesday | News
Hong Kong study finds that smoking increases risk of COVID-19

Researchers from the School of Public Health, LKS Faculty of Medicine of The University of Hong Kong (HKUMed), in collab...

March 9, 2022 | Wednesday | News
WHO updates treatment guidelines for molnupiravir

The World Health Organisation (WHO) has updated its living guidelines on COVID-19 therapeutics to include a conditional ...

March 4, 2022 | Friday | News
Achieving equitable access and universal coverage goals for COVID-19 vaccines

The pandemic has created an unprecedented pressing need for the development of novel vaccines and their equitable distri...

February 4, 2022 | Friday | Opinion
Australia approves Pfizer booster for 16–17 year olds

The Therapeutic Goods Administration (TGA) in Australia has approved the Pfizer COVID-19 booster dose for young people a...

January 28, 2022 | Friday | News
Australia provisionally approves oral COVID-19 pills by Merck & Pfizer

The Therapeutic Goods Administration (TGA) in Australia has issued provisional approval of the first oral treatments for...

January 21, 2022 | Friday | News
Australia pitches $24 M for telehealth to tackle growing cases of omicron

As Omicron case numbers grow, the Australian Government will make temporary changes to Telehealth to give general p...

January 18, 2022 | Tuesday | News
Australia gives recognition to Sputnik V vaccine for international travel

The Therapeutic Goods Administration (TGA) in Australia has determined that an additional COVID-19 vaccine, the two dose...

January 17, 2022 | Monday | News
Singapore recommends booster dose at no later than 9 months

The Expert Committee on COVID-19 Vaccination (EC19V) in Singapore recommends that all vaccinated persons aged 18 years a...

January 6, 2022 | Thursday | News
T-cell responses by vaccines and boosters effective against Omicron: Australian study

Research from the University of Melbourne in Australia and Hong Kong University of Science and Technology (HKU...

January 3, 2022 | Monday | News
Japan-funded study explores antibodies to neutralise omicron

An international team of scientists have identified antibodies that neutralize omicron and other SARS-CoV-2 variants. Th...

December 28, 2021 | Tuesday | News
Nasal spray to fight COVID-19 heads to clinical trial in Australia

An at-home nasal spray treatment for COVID-19 will be put to the test by Melbourne biomedical researchers, as the Univer...

December 24, 2021 | Friday | News
New Zealand approves use of Ronapreve to prevent & treat COVID-19

The Ministry of Health’s medicine regulatory arm Medsafe in New Zealand has approved a new COVID-19 medicine Ronap...

December 23, 2021 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls